Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)
Others
Ratios

Benitec Biopharma (BNTC) Shares Outstanding (Weighted Average) (2019 - 2024)

Benitec Biopharma's Shares Outstanding (Weighted Average) history spans 7 years, with the latest figure at $34.6 million for Q1 2025.

  • For Q1 2025, Shares Outstanding (Weighted Average) rose 117.68% year-over-year to $34.6 million; the TTM value through Mar 2025 reached $34.6 million, up 117.68%, while the annual FY2024 figure was $18.4 million, 1225.17% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q1 2025 was $34.6 million at Benitec Biopharma, up from $32.6 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $34.6 million in Q1 2025 and bottomed at $480688.0 in Q2 2022.
  • The 5-year median for Shares Outstanding (Weighted Average) is $4.7 million (2021), against an average of $10.2 million.
  • The largest annual shift saw Shares Outstanding (Weighted Average) tumbled 92.19% in 2022 before it skyrocketed 1276.35% in 2024.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $8.2 million in 2021, then plummeted by 80.16% to $1.6 million in 2022, then skyrocketed by 45.98% to $2.4 million in 2023, then surged by 1276.35% to $32.6 million in 2024, then increased by 6.1% to $34.6 million in 2025.
  • Per Business Quant, the three most recent readings for BNTC's Shares Outstanding (Weighted Average) are $34.6 million (Q1 2025), $32.6 million (Q4 2024), and $27.9 million (Q3 2024).